AGIO(Agios Pharmaceuticals, Inc.) · 财务报表

AGIO(Agios Pharmaceuticals, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$0$14.24M$26.82M$36.50M$54.03M
毛利润$0$12.54M$23.94M$32.33M$47.68M
营业利润−$378.42M−$389.05M−$391.49M−$425.74M−$472.13M
净利润$1.60B−$231.80M−$352.09M$673.73M−$412.78M
经营现金流−$407.32M−$309.48M−$296.06M−$389.84M−$372.98M
自由现金流−$413.06M−$314.36M−$297.06M−$391.53M−$377.29M
摊薄每股收益$26.55$-4.23$-6.33$11.64$-7.12

Agios Pharmaceuticals, Inc. AGIO